These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 22454071)

  • 1. Antisense genes to induce exon inclusion.
    Nlend RN; Schümperli D
    Methods Mol Biol; 2012; 867():325-47. PubMed ID: 22454071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation.
    Meyer K; Marquis J; Trüb J; Nlend Nlend R; Verp S; Ruepp MD; Imboden H; Barde I; Trono D; Schümperli D
    Hum Mol Genet; 2009 Feb; 18(3):546-55. PubMed ID: 19010792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes.
    Marquis J; Kämpfer SS; Angehrn L; Schümperli D
    Gene Ther; 2009 Jan; 16(1):70-7. PubMed ID: 18701908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.
    Baughan T; Shababi M; Coady TH; Dickson AM; Tullis GE; Lorson CL
    Mol Ther; 2006 Jul; 14(1):54-62. PubMed ID: 16580882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using mini-genes to identify factors that modulate alternative splicing.
    Morse R; Todd AG; Young PJ
    Methods Mol Biol; 2012; 867():349-62. PubMed ID: 22454072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering U7snRNA gene to reframe transcripts.
    Goyenvalle A
    Methods Mol Biol; 2012; 867():259-71. PubMed ID: 22454067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U1 snRNA as an effective vector for stable expression of antisense molecules and for the inhibition of the splicing reaction.
    Martone J; De Angelis FG; Bozzoni I
    Methods Mol Biol; 2012; 867():239-57. PubMed ID: 22454066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is RNA manipulation a viable therapy for spinal muscular atrophy?
    Horne C; Young PJ
    J Neurol Sci; 2009 Dec; 287(1-2):27-31. PubMed ID: 19758605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.
    Kashima T; Manley JL
    Nat Genet; 2003 Aug; 34(4):460-3. PubMed ID: 12833158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.
    Cartegni L; Krainer AR
    Nat Genet; 2002 Apr; 30(4):377-84. PubMed ID: 11925564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.
    Brichta L; Hofmann Y; Hahnen E; Siebzehnrubl FA; Raschke H; Blumcke I; Eyupoglu IY; Wirth B
    Hum Mol Genet; 2003 Oct; 12(19):2481-9. PubMed ID: 12915451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.
    Goyenvalle A; Vulin A; Fougerousse F; Leturcq F; Kaplan JC; Garcia L; Danos O
    Science; 2004 Dec; 306(5702):1796-9. PubMed ID: 15528407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 multiplication by a modified U7 snRNA inducing Tat and Rev exon skipping.
    Asparuhova MB; Marti G; Liu S; Serhan F; Trono D; Schümperli D
    J Gene Med; 2007 May; 9(5):323-34. PubMed ID: 17474072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H; Shafey D; Moores JN; Kothary R
    J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 Splicing.
    Odermatt P; Trüb J; Furrer L; Fricker R; Marti A; Schümperli D
    Mol Ther; 2016 Oct; 24(10):1797-1805. PubMed ID: 27456062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of antisense sequence length for modified mouse U7 small nuclear RNA to induce efficient pre-messenger RNA splicing modulation in vitro.
    Shimo T; Ueda O; Yamamoto S
    PLoS One; 2024; 19(7):e0305012. PubMed ID: 38980892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-target antisense U7 snRNAs promote efficient skipping of an aberrant exon in three human beta-thalassemic mutations.
    Suter D; Tomasini R; Reber U; Gorman L; Kole R; Schümperli D
    Hum Mol Genet; 1999 Dec; 8(13):2415-23. PubMed ID: 10556289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy.
    DiMatteo D; Callahan S; Kmiec EB
    Exp Cell Res; 2008 Feb; 314(4):878-86. PubMed ID: 18078930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular pH change modulates the exon 7 splicing in SMN2 mRNA.
    Chen YC; Yuo CY; Yang WK; Jong YJ; Lin HH; Chang YS; Chang JG
    Mol Cell Neurosci; 2008 Oct; 39(2):268-72. PubMed ID: 18672065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.